Patience David's Form 4 filing
Accelerate Diagnostics, Inc (AXDX) · filed Apr 10, 2024
- Accession no.
- 0001104659-24-045899
- Filed
- Apr 10, 2024
- Trade date
- Apr 9, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $11.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patience DavidCIK 0001970009 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | MOption exerciseAcquired | +37,468 | $0.00F1 | $0 | 63,715 | Direct | |
| Apr 9, 2024 | Common Stock | SSaleDisposed | −13,296 | $0.87 | −$11,567.52 | 50,419 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | MOption exerciseDisposed | −37,468 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On March 5, 2024, the reporting person was granted a total of 37,468 restricted stock units ("RSUs"), which vest on April 9, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
Referenced by the price of 1 transaction in Table I.